Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PTE PolarityTE, Inc. daily Stock Chart
PTE [NASD]
PolarityTE, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-3.96 Insider Own31.10% Shs Outstand25.20M Perf Week6.14%
Market Cap148.18M Forward P/E- EPS next Y-4.33 Insider Trans- Shs Float13.31M Perf Month-14.91%
Income-83.70M PEG- EPS next Q-1.05 Inst Own45.40% Short Float39.72% Perf Quarter-51.32%
Sales3.70M P/S40.05 EPS this Y82.20% Inst Trans-10.85% Short Ratio12.99 Perf Half Y-59.31%
Book/sh2.62 P/B2.24 EPS next Y7.10% ROA- Target Price30.67 Perf Year-80.59%
Cash/sh1.77 P/C3.32 EPS next 5Y15.00% ROE- 52W Range4.96 - 41.22 Perf YTD-56.41%
Dividend- P/FCF- EPS past 5Y43.60% ROI-25.40% 52W High-85.74% Beta1.35
Dividend %- Quick Ratio5.60 Sales past 5Y-54.50% Gross Margin41.50% 52W Low18.55% ATR0.56
Employees156 Current Ratio5.60 Sales Q/Q48733.30% Oper. Margin- RSI (14)40.65 Volatility7.09% 9.86%
OptionableYes Debt/Eq0.05 EPS Q/Q19.30% Profit Margin- Rel Volume0.37 Prev Close5.93
ShortableYes LT Debt/Eq0.03 EarningsJun 13 Payout- Avg Volume407.08K Price5.88
Recom2.30 SMA20-3.22% SMA50-22.67% SMA200-56.35% Volume152,520 Change-0.84%
Mar-21-19Initiated Evercore ISI Outperform $26
Jan-28-19Initiated Northland Capital Outperform $50
Jan-28-19Initiated National Securities Sell $5
Dec-20-18Initiated Piper Jaffray Overweight
Jun-19-19 12:30PM  What Type Of Shareholder Owns PolarityTE, Inc.'s (NASDAQ:PTE)? Simply Wall St.
Jun-12-19 11:49AM  Weekly CFO Buys Highlight GuruFocus.com
Jun-10-19 10:09AM  PolarityTE Shares Rally On Positive Readout From Skin Graft Study In Diabetic Foot Ulcers Benzinga
08:00AM  PolarityTE Announces Final Clinical Data from Pilot Study Showing Closure of Diabetic Foot Ulcers Using SkinTE PR Newswire
Jun-08-19 05:38PM  Ready Trader One: Events, Stocks To Watch At E3 Benzinga
Jun-03-19 08:00AM  PolarityTE Creates Office of the Chief Executive to Focus on Commercialization and Operational Performance PR Newswire
May-31-19 01:33PM  Analysts Recommend These 3 Falling Knives GuruFocus.com
May-21-19 08:00AM  Final Data from Pilot Study on Use of SkinTE for Diabetic Foot Ulcers Accepted as Late-Breaking Abstract at the American Diabetes Association's 79th Scientific Sessions Conference PR Newswire
May-20-19 11:26AM  Implied Volatility Surging for PolarityTE (PTE) Stock Options Zacks -9.79%
May-10-19 09:55AM  3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates Zacks
07:30AM  PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE PR Newswire
07:16AM  PolarityTE Reports First Calendar Quarter 2019 Results PR Newswire
May-02-19 09:00AM  Should You Be Concerned About PolarityTE, Inc.'s (NASDAQ:PTE) Historical Volatility? Simply Wall St. +6.72%
May-01-19 08:00AM  PolarityTE to Report Calendar First Quarter Financial Results on May 10, 2019 PR Newswire
Apr-24-19 08:00AM  SkinTE Clinical Data to be Presented, PolarityTE to Host Booth and SkinTE Event at Symposium on Advanced Wound Care (SAWC) Spring, Wound Healing Society Meeting PR Newswire
Apr-10-19 11:00AM  Why PolarityTE Is Sinking Today Motley Fool -10.18%
09:30AM  PolarityTE Announces Pricing of Public Offering of Common Stock PR Newswire
Apr-09-19 04:01PM  PolarityTE Announces Public Offering of Common Stock PR Newswire
Apr-02-19 04:34PM  Lifshitz & Miller LLP Announces Investigation of Bloom Energy Corporation, First Choice Healthcare Solutions, Inc., Nutanix, Inc., PolarityTE, Inc., Revlon, Inc., Tivity Health, Inc., WellCare Health Plans, Inc., and Whitestone REIT PR Newswire
Apr-01-19 08:00AM  PolarityTE Enrolls First Patients in Two Clinical Trials Evaluating SkinTE for the Treatment of Chronic Wounds PR Newswire
Mar-29-19 08:00AM  PolarityTE Announces Richard Hague, Formerly from Sanofi, Genzyme and Recently Anika Therapeutics as Chief Operating Officer PR Newswire
Mar-27-19 08:00AM  Clinical Outcomes Data on SkinTE from Lower Extremity Chronic Wounds to be Presented at Diabetic Limb Salvage (DLS) Conference PR Newswire
Mar-21-19 08:00AM  PolarityTE Hosts Symposium Featuring SkinTE-Treated Burn Survivor, New Clinical Data at American Burn Association Annual Meeting PR Newswire +9.60%
Mar-19-19 05:00PM  PolarityTE to Present at Oppenheimer 29th Annual Healthcare Conference PR Newswire
02:15PM  RM LAW Announces Investigation of PolarityTE, Inc. PR Newswire
01:06PM  Federman & Sherwood Investigates PolarityTE, Inc. for Possible Violations of Federal Securities Laws Business Wire
10:47AM  PolarityTE (PTE) Investigation: Bernstein Liebhard LLP Announces Investigation of PolarityTE, Inc. - PTE GlobeNewswire
Mar-18-19 07:56PM  Bragar Eagel & Squire, P.C. is Investigating PolarityTE, Inc. (PTE) on Behalf of Stockholders and Encourages PTE Investors to Contact the Firm GlobeNewswire -15.64%
05:40PM  PolarityTE (PTE) Investigation: Bernstein Liebhard LLP Announces Investigation Of PolarityTE, Inc. - PTE PR Newswire
04:20PM  Why PolarityTE Stock Tanked Today Motley Fool
02:16PM  Biotech's shares tumble after it says SEC is looking into possible manipulation CNBC
07:00AM  PolarityTE Reports Results and Corporate Update for Two-Month Transition Period Ended December 31, 2018 PR Newswire
Mar-14-19 10:20AM  Read This Before Buying PolarityTE, Inc. (NASDAQ:PTE) Shares Simply Wall St.
Mar-13-19 08:45AM  PolarityTE to Attend Medlab Asia Pacific and Asia Health 2019 Conferences PR Newswire
Mar-11-19 11:39AM  Why PolarityTE Stock Is Shooting Higher Today Motley Fool +22.25%
10:30AM  Will Polarity (PTE) Report Negative Q1 Earnings? What You Should Know Zacks
Mar-06-19 04:01PM  PolarityTE to Present at the 39th Annual Cowen Healthcare Conference and at the 13th Annual Canaccord Genuity Musculoskeletal Conference PR Newswire
Mar-05-19 08:00AM  Congressional Health Care Innovation Showcase to Feature PolarityTE PR Newswire
Feb-27-19 08:00AM  PolarityTE Presents Platform Technology at Department of Defense Pacific Operational Science and Technology (POST) Conference PR Newswire
Feb-25-19 10:10AM  Zacks.com featured expert Kevin Matras highlights: Shenandoah Telecommunications, Honda Motor, PolarityTE, Ubiquiti Networks and Titan Machinery Zacks
Feb-22-19 09:06AM  5 Stocks to Buy as New Analysts Initiate Coverage Zacks
Feb-06-19 07:12AM  PolarityTE, Inc. (NASDAQ:PTE): The Best Of Both Worlds Simply Wall St.
Feb-01-19 11:30AM  LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index ACCESSWIRE
08:00AM  Boswick Burn and Wound Symposium: New Data to be Presented on Preclinical and Clinical Use of SkinTE PR Newswire
Jan-29-19 04:15PM  PolarityTE Names Board Member David Seaburg as President of Corporate Development PR Newswire
Jan-23-19 08:50AM  Implied Volatility Surging for PolarityTE (PTE) Stock Options Zacks
08:00AM  World Stem Cell Summit: PolarityTE to Present Abstract on Regenerative Platform Technology PR Newswire
Jan-14-19 07:00AM  PolarityTE Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
Jan-07-19 08:00AM  PolarityTE Expands Contract Services Business with Addition of Jon Burrows PR Newswire -6.13%
Jan-03-19 08:00AM  PolarityTE to Report Fiscal Fourth Quarter Financial Results on January 14, 2019 PR Newswire
Dec-28-18 08:00AM  PolarityTE Registers OsteoTE with U.S. Food and Drug Administration PR Newswire
Dec-27-18 08:00AM  PolarityTE to Participate in Corporate Access Event in San Francisco, January 7-9, 2019 PR Newswire
Dec-24-18 10:21AM  Investors Are Undervaluing PolarityTE, Inc. (NASDAQ:PTE) By 32.74% Simply Wall St.
Dec-19-18 08:00AM  PolarityTE and University Hospitals Cleveland Medical Center Announce System-Wide Approval of SkinTE PR Newswire +8.85%
Dec-11-18 08:00AM  PolarityTE Announces Former FDA Official and Johnson & Johnson Executive Minnie Baylor-Henry Joins Board of Directors PR Newswire +17.64%
Dec-04-18 08:00AM  PolarityTE to Present SkinTE Clinical Outcomes at Innovations in Wound Healing Conference PR Newswire -7.19%
Nov-29-18 08:00AM  PolarityTE Announces Recognition of SkinTE as Finalist for Fierce Innovation Awards Biotech Innovation PR Newswire
Nov-27-18 07:00AM  PolarityTE Announces Matt Kemp as Chief Commercial Officer PR Newswire
Nov-21-18 08:00AM  PolarityTE Receives Unique HCPCS Q-Code for SkinTE for Product Reimbursement from CMS PR Newswire +8.31%
Nov-15-18 08:00AM  PolarityTE to Participate in Piper Jaffray 30th Annual Healthcare Conference PR Newswire
Nov-14-18 08:00AM  PolarityTE to Participate in Evercore ISI Healthcare Conference PR Newswire
Nov-07-18 08:00AM  PolarityTE to Sponsor Epidermolysis Bullosa Research Partnership Event "ACTion for Jackson" in New York PR Newswire
Nov-02-18 08:00AM  PolarityTE® to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum PR Newswire
Nov-01-18 08:00AM  PolarityTE® Announces Presentation of SkinTE Clinical Outcomes at Symposium on Advanced Wound Care PR Newswire
Oct-29-18 03:02PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against PolarityTE, Inc. (PTE) and Encourages PTE Investors to Contact the Firm GlobeNewswire
08:00AM  PolarityTE® Supports Development of Utah Biotech and Life Sciences Community PR Newswire
Oct-18-18 12:29PM  PolarityTE Issues Statement on Misleading Internet Post PR Newswire -17.05%
08:00AM  PolarityTE® Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access PR Newswire
Oct-15-18 07:24PM  Robbins Arroyo LLP: PolarityTE, Inc. (PTE) Misled Shareholders According to a Class Action Business Wire +8.76%
Oct-12-18 08:02AM  Moving Average Crossover Alert: PolarityTE (PTE) Zacks -9.81%
Oct-09-18 10:52AM  Cool Mara Riot, Part Two: Securities-Fraud Case Against South Florida Group Reverberates Through Additional Companies Benzinga
09:15AM  PolarityTE® Announces Reporting of Apparent Intentional Market Manipulation by Third Parties to Regulatory Authorities PR Newswire
Oct-05-18 08:00AM  PolarityTE® to Present at the DFCon 2018 Diabetic Foot Global Conference on Clinical Outcomes Associated with SkinTE PR Newswire
Sep-26-18 08:00AM  PolarityTE Announces the Expansion of the Sales Team in the Regional Market Release of SkinTE PR Newswire -10.27%
Sep-24-18 08:00AM  PolarityTE Announces Presentations of SkinTE Clinical Results at Upcoming Plastic Surgery Conferences PR Newswire
Sep-20-18 08:00AM  PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference PR Newswire +13.37%
Mar-23-18 05:08AM  Should Parcel Technik SA.s (WSE:PTE) Recent Earnings Decline Worry You? Simply Wall St.
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
open in yahoo | open in reuters | open in google